ASX Equity Snapshot

TLX Weekly Equity Report

Telix Pharmaceuticals Limited

Interactive chart JSON snapshot
Latest Close 13.60 AUD 12 Jun 2026
1W Return 2.2% latest completed week
4W Return -7.6% short-term follow-through
12W Return 6.7% quarterly tape
Trend Breadth 7.7% 4 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
Company Brief

What the company does

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and …

Snapshot

What the weekly tape is saying

TLX closed the latest completed week at 13.60 AUD. The 4-week return is -7.6% and the 12-week return is 6.7%. Trend Signal is active, Market Dynamics is 0.53. Setup signature: Risk-first tape with a 30/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 7.4%
Volume 1.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 18 Persistence of active Trend Signal over the last year and current streak.
Momentum 38 Blend of 4-week and 12-week follow-through.
Dynamics 56 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 17 Relative leadership and short-term RS change.
Volume 49 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
12.66 AUD
Vs Trend Line
7.4%
Fair Value
16.74 AUD
Vs Fair Value
-18.8%
52W High
26.25 AUD
52W Low
8.26 AUD
Drawdown
-48.2%
Range Position
29.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 2.2%
4W -7.6%
12W 6.7%
26W -1.0%
52W -45.1%

Trend read

Active Streak
4 weeks
52W Active Weeks
4
52W Active Breadth
7.7%
Sector Scope
AU Healthcare
Sector Rank
42 of 146
Sector Percentile
71.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.53
4W MD Change
-43.7%
Relative Strength
-9.64
4W RS Change
-49.0%
Expectation
Undecided
Probability
51.69%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
13.7M
13W Average
11.9M
52W Average
11.9M
Vs 13W
1.2x
Vs 52W
1.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
6.4%
52W Volatility
7.3%
Upside Weeks
20
Downside Weeks
31
Downside Breadth
59.6%
Avg Gain / Loss
6.0% / -5.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
ASX
Country
AU
Sector
Healthcare
Industry
Biotechnology
Currency
AUD
Market Cap
4.4B

Opportunity signals

  • Trend Signal is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 13.60 AUD 2.2% 12.66 AUD 16.74 AUD 0.53 -9.64 13.7M On
5 Jun 2026 13.31 AUD 2.1% 12.68 AUD 16.73 AUD 0.62 -11.08 10.0M On
29 May 2026 13.03 AUD -2.2% 12.73 AUD 16.71 AUD 0.72 -15.38 10.7M On
22 May 2026 13.32 AUD -9.5% 12.83 AUD 16.69 AUD 0.87 -14.25 10.4M On
15 May 2026 14.72 AUD -0.2% 12.94 AUD 16.68 AUD 0.94 -6.47 6.4M Off
8 May 2026 14.75 AUD -5.3% 13.01 AUD 16.66 AUD 1.15 -8.85 6.3M Off
1 May 2026 15.57 AUD 4.5% 13.02 AUD 16.64 AUD 1.25 -5.17 8.4M Off
24 Apr 2026 14.90 AUD 1.8% 13.01 AUD 16.61 AUD 1.26 -11.44 9.8M Off
17 Apr 2026 14.64 AUD 0.0% 13.01 AUD 16.58 AUD 1.33 -16.14 26.4M Off
10 Apr 2026 14.64 AUD 13.1% 13.01 AUD 16.55 AUD 1.34 -17.61 11.1M Off
3 Apr 2026 12.95 AUD -5.1% 12.97 AUD 16.51 AUD 1.22 -25.18 10.7M Off
27 Mar 2026 13.65 AUD 7.1% 13.00 AUD 16.47 AUD 0.95 -21.72 10.0M Off
20 Mar 2026 12.75 AUD 12.9% 13.03 AUD 16.43 AUD 0.59 -27.39 20.4M Off
13 Mar 2026 11.29 AUD 5.0% 13.22 AUD 16.39 AUD 0.14 -38.26 17.3M Off